John Knight

John Knight

University of Glasgow

H-index: 22

Europe-United Kingdom

About John Knight

John Knight, With an exceptional h-index of 22 and a recent h-index of 18 (since 2020), a distinguished researcher at University of Glasgow, specializes in the field of Cancer, protein synthesis, drug responses, RNA damage.

His recent articles reflect a diverse array of research interests and contributions to the field:

RNA damage: the forgotten target of clinical compounds

Ribosome Quality Control Mechanism Mitigates the Cytotoxic Impacts of Ribosome Collisions Induced by 5-Fluorouracil

eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancers

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24Bst Mouse

Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K

MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression

Tuning protein synthesis for cancer therapy

Translation initiation in cancer at a glance

John Knight Information

University

Position

Research Scientist, Beatson Institute for Cancer Research

Citations(all)

1650

Citations(since 2020)

1189

Cited By

824

hIndex(all)

22

hIndex(since 2020)

18

i10Index(all)

27

i10Index(since 2020)

25

Email

University Profile Page

Google Scholar

John Knight Skills & Research Interests

Cancer

protein synthesis

drug responses

RNA damage

Top articles of John Knight

RNA damage: the forgotten target of clinical compounds

Frontiers in RNA Research

2023/9/6

Ribosome Quality Control Mechanism Mitigates the Cytotoxic Impacts of Ribosome Collisions Induced by 5-Fluorouracil

bioRxiv

2023

eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancers

bioRxiv

2023

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24Bst Mouse

The Journal of Investigative Dermatology

2022/12

Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K

Elife

2021/12/13

MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression

Cancer discovery

2021/5/1

Tuning protein synthesis for cancer therapy

Molecular & Cellular Oncology

2021/3/4

Translation initiation in cancer at a glance

2021/1/1

The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

Nature genetics

2021/1

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

Oncogene

2020/2

Control of translation elongation in health and disease

2020/3/1

See List of Professors in John Knight University(University of Glasgow)

Co-Authors

academic-engine